NM_016203.4(PRKAG2):c.*953T>A AND Hypertrophic cardiomyopathy 6
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- Feb 4, 2019
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV001164816.4
Allele description [Variation Report for NM_016203.4(PRKAG2):c.*953T>A]
NM_016203.4(PRKAG2):c.*953T>A
Condition(s)
-
Nivolumab (Opdivo)
Nivolumab (Opdivo)
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Dec 24, 2023